Chiron

For profitContributed to NME

Also known as: Biocine | CHIRON | Chiron company: Clinical Research and Medical Affairs | Chiron Corporation | Chiron s.r.l. Beijing Representative Office

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Jun 1, 1997

First marketed drug

May 5, 1992

First NDA

May 5, 1992

Last known activity

Feb 1, 2006

Acquired by Novartis on Jan 1, 2006

Timeline

1980s

Jan 1, 1981
Chiron— Founded

1990s

Jan 1, 1991
Cetus— Acquired
May 5, 1992
aldesleukin— Marketing Organization
May 5, 1992
aldesleukin— NDA Organization

2000s

Jan 1, 2000
PathoGenesis— Acquired
Feb 19, 2002
Matrix Pharmaceutical— Acquired
Jan 1, 2006
Novartis— Acquired By

Drugs by trial phase (26 distinct, 39 trials)

Phase 4 (3 own, 0 via acquisition)

Phase 3 (2 own, 2 via acquisition)

Phase 2 (9 own, 2 via acquisition)

Phase 1 (4 own, 0 via acquisition)

Other trials (4 own, 0 via acquisition)

Marketed drugs (1)

aldesleukin

Subsidiaries (3 direct, 3 total across the full acquisition tree)

Recent trials (35)

NCT00000774CollaboratorPhase 1—
NCT00311493Study directorPhase 4Feb 1, 2006
NCT00616564CollaboratorPhase 2Feb 1, 2006
NCT00310648CollaboratorPhase 3Jan 1, 2006
NCT00250861CollaboratorPhase 2Oct 1, 2005
NCT00110812CollaboratorPhase 2Sep 1, 2005
NCT00149162CollaboratorPhase 3Mar 1, 2005
NCT00100737Lead sponsorPhase 2Jan 6, 2005
NCT00100906CollaboratorPhase 2Aug 1, 2004
NCT00113282CollaboratorPhase 2Jun 1, 2004
NCT01270906CollaboratorPhase 1Dec 1, 2003
NCT00120185CollaboratorPhase 2Dec 1, 2003
NCT00054873Lead sponsorPhase 2Nov 1, 2003
NCT00262015Lead sponsorPhase 4Sep 1, 2003
NCT00051688Lead sponsorPhase 2Jun 1, 2003

Details

Founded: Emeryville, CA, US Jan 1, 1981
First NDA: May 5, 1992
Last known activity: Feb 1, 2006

Designations held

Orphan drug